PNC Financial Services Group
IRWD icon

PNC Financial Services Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

PNC Financial Services Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-106
Closed -$156 – 4994
2025
Q1 		$156 Sell
106
-7,338
-99% -$17.5K ﹤0.01% 4793
2024
Q4 		$33K Buy
7,444
+214
+3% +$868 ﹤0.01% 3317
2024
Q3 		$29.8K Buy
7,230
+2,483
+52% +$13.3K ﹤0.01% 3328
2024
Q2 		$31K Buy
4,747
+2,820
+146% +$19.9K ﹤0.01% 3274
2024
Q1 		$16.8K Sell
1,927
-2,456
-56% -$29.8K ﹤0.01% 3534
2023
Q4 		$50.1K Buy
4,383
+2,645
+152% +$26.2K ﹤0.01% 2973
2023
Q3 		$16.7K Sell
1,738
-1,909
-52% -$18.7K ﹤0.01% 3518
2023
Q2 		$38.8K Buy
3,647
+1,067
+41% +$11.5K ﹤0.01% 3206
2023
Q1 		$27.1K Sell
2,580
-431
-14% -$4.83K ﹤0.01% 3344
2022
Q4 		$37.3K Sell
3,011
-7,941
-73% -$90.1K ﹤0.01% 3146
2022
Q3 		$114K Sell
10,952
-13,525
-55% -$153K ﹤0.01% 2451
2022
Q2 		$283K Sell
24,477
-16,776
-41% -$198K ﹤0.01% 1912
2022
Q1 		$518K Buy
41,253
+2,402
+6% +$27.5K ﹤0.01% 1623
2021
Q4 		$452K Sell
38,851
-37
-0.1% -$454 ﹤0.01% 1766
2021
Q3 		$509K Buy
38,888
+10,949
+39% +$142K ﹤0.01% 1595
2021
Q2 		$361K Sell
27,939
-4,629
-14% -$53K ﹤0.01% 1833
2021
Q1 		$364K Sell
32,568
-8,080
-20% -$85.4K ﹤0.01% 1796
2020
Q4 		$462K Sell
40,648
-6,840
-14% -$74.8K ﹤0.01% 1529
2020
Q3 		$426K Buy
47,488
+6,884
+17% +$68.4K ﹤0.01% 1437
2020
Q2 		$419K Sell
40,604
-2,796
-6% -$28.6K ﹤0.01% 1486
2020
Q1 		$437K Buy
43,400
+12,256
+39% +$144K ﹤0.01% 1360
2019
Q4 		$415K Sell
31,144
-1,300
-4% -$14.3K ﹤0.01% 1586
2019
Q3 		$278K Buy
32,444
+956
+3% +$9.29K ﹤0.01% 1945
2019
Q2 		$345K Buy
31,488
+3,355
+12% +$37.6K ﹤0.01% 1853
2019
Q1 		$319K Sell
28,133
-623
-2% -$6.96K ﹤0.01% 1872
2018
Q4 		$250K Sell
28,756
-110,332
-79% -$1.27M ﹤0.01% 1918
2018
Q3 		$2.15M Buy
139,088
+118,774
+585% +$1.88M ﹤0.01% 1048
2018
Q2 		$325K Buy
20,314
+20,199
+17,564% +$299K ﹤0.01% 1901
2018
Q1 		$1K Sell
115
-279,814
-100% -$3.49M ﹤0.01% 4125
2017
Q4 		$3.51M Sell
279,929
-64,490
-19% -$842K ﹤0.01% 851
2017
Q3 		$4.55M Buy
344,419
+29,324
+9% +$404K ﹤0.01% 743
2017
Q2 		$4.98M Buy
315,095
+4,792
+2% +$69.6K 0.01% 676
2017
Q1 		$4.43M Buy
310,303
+31,247
+11% +$427K ﹤0.01% 713
2016
Q4 		$3.57M Buy
279,056
+94,926
+52% +$1.2M ﹤0.01% 782
2016
Q3 		$2.45M Buy
184,130
+16,902
+10% +$198K ﹤0.01% 895
2016
Q2 		$1.83M Buy
167,228
+166,405
+20,219% +$1.63M ﹤0.01% 978
2016
Q1 		$8K Sell
823
-1,335
-62% -$11K ﹤0.01% 3648
2015
Q4 		$21K Hold
2,158
– – ﹤0.01% 3277
2015
Q3 		$19K Sell
2,158
-50
-2% -$467 ﹤0.01% 3396
2015
Q2 		$23K Buy
2,208
+351
+19% +$4.08K ﹤0.01% 3436
2015
Q1 		$25K Hold
1,857
– – ﹤0.01% 3398
2014
Q4 		$23K Sell
1,857
-948
-34% -$10.8K ﹤0.01% 3101
2014
Q3 		$31K Hold
2,805
– – ﹤0.01% 2882
2014
Q2 		$35K Buy
2,805
+2,232
+390% +$24.3K ﹤0.01% 2724
2014
Q1 		$6K Buy
573
+286
+100% +$3.22K ﹤0.01% 3196
2013
Q4 		$3K Sell
287
-2,468
-90% -$22.2K ﹤0.01% 3198
2013
Q3 		$28K Sell
2,755
-58
-2% -$569 ﹤0.01% 2705
2013
Q2 		$24K Buy
+2,813
New +$34.1K ﹤0.01% 2675

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group's IRWD Position: Q2 2025 in Review

PNC Financial Services Group sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 106 shares — an estimated $156 sold.

PNC Financial Services Group first reported a position in IRWD in Q2 2013 and held it in 48 quarters. The position peaked at $4.98M in Q2 2017. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • PNC Financial Services Group reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 106 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $156.
  • PNC Financial Services Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 48 quarters.
  • PNC Financial Services Group's Ironwood Pharmaceuticals position peaked at $4.98M in Q2 2017.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.